Close Menu

NEW YORK (360Dx) – Investors in many diagnostics firms saw a healthy return in 2017 as the share prices of several companies in the 360Dx Index more than doubled year over year, resulting in an overall increase of 30 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.